Dealing with New Psychoactive Substances (NPS) in emergency medicine

被引：0
|
作者：
Marinowitz, R. [1 ]
Strube, J. [1 ]
Schaper, A. [1 ]
机构：
[1] Georg August Univ Gottingen, Giftinformat Zentrum Nord, Gottingen, Germany
来源：
NOTFALL & RETTUNGSMEDIZIN | 2023年 / 26卷 / 02期
关键词：
D O I：
10.1007/s10049-022-01117-6
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [41] New psychoactive substances: Are there any good options for regulating new psychoactive substances?
    Reuter, Peter
    Pardo, Bryce
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 40 : 117 - 122
  • [42] Evaluation of knowledge of new psychoactive substances among emergency department practitioners
    Perier, Damien
    Eiden, Celine
    Beringer, Juline
    Peyriere, Helene
    Sebbane, Mustapha
    THERAPIE, 2022, 77 (06): : 780 - 780
  • [43] Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021
    Gundersen, Per Ole M.
    Pasin, Daniel
    Slordal, Lars
    Spigset, Olav
    Josefsson, Martin
    FORENSIC SCIENCE INTERNATIONAL, 2024, 361
  • [44] Micro-electrode array (MEA) recordings for neurotoxicity screening of new psychoactive substances (NPS)
    Zwartsen, A.
    Hondebrink, L.
    Verboven, A. H. A.
    Drega, S. W.
    Schmeink, S.
    de Groot, M. W. G. D. M.
    van Kleef, R. G. D. M.
    Wijnolts, F. M. J.
    de Groot, A.
    Meulenbelt, J.
    Westerink, R. H. S.
    TOXICOLOGY LETTERS, 2016, 259 : S207 - S207
  • [45] Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps
    Miliano, Cristina
    Margiani, Giulia
    Fattore, Liana
    De Luca, Maria Antonietta
    BRAIN SCIENCES, 2018, 8 (07):
  • [46] The application of 19F NMR spectroscopy for the analysis of fluorinated new psychoactive substances (NPS)
    Liu, Cui-mei
    Song, Chun-hui
    Jia, Wei
    Hua, Zhen-dong
    Liao, Qi
    FORENSIC SCIENCE INTERNATIONAL, 2022, 340
  • [47] The use of new psychoactive substances (NPS) in young people and its association with mental health issues
    Orsolini, L.
    Chiappini, S.
    Corkery, J.
    Guirguis, A.
    Papanti, G.
    Schifano, F.
    EUROPEAN PSYCHIATRY, 2020, 63 : S55 - S55
  • [48] Understanding the risks associated with the use of new psychoactive substances (NPS): High variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products
    Zamengo, Luca
    Frison, Giampietro
    Bettin, Chiara
    Sciarrone, Rocco
    TOXICOLOGY LETTERS, 2014, 229 (01) : 220 - 228
  • [49] Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act
    Webb, Nicholas E.
    Wood, David M.
    Greene, Shaun L.
    Hunter, Laura J.
    Archer, John R. H.
    Dines, Alison M.
    Dargan, Paul I.
    CLINICAL TOXICOLOGY, 2019, 57 (01) : 36 - 41
  • [50] A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand
    Wilkins, Chris
    ADDICTION, 2014, 109 (10) : 1580 - 1586
12345